Cargando…

Correlation between Galectin-3 and Adverse Outcomes in Myocardial Infarction Patients: A Meta-Analysis

BACKGROUND: Acute myocardial infarction (AMI) is a disease with high morbidity and mortality. Some new biomarkers can help us to improve the life quality and prognosis of AMI patients. OBJECTIVE: We therefore performed a systematic review and meta-analysis on the use of galectin-3 (gal3) for assessi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Lei, Chen, Kan, Han, Zhihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229552/ https://www.ncbi.nlm.nih.gov/pubmed/32455000 http://dx.doi.org/10.1155/2020/7614327

Ejemplares similares

Labeling galectin-3 for the assessment of myocardial infarction in rats
por: Arias, Teresa, et al.
Publicado: (2014)

Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction
por: Gagno, Giulia, et al.
Publicado: (2019)

Galectin-1 in Early Acute Myocardial Infarction
por: Al-Salam, Suhail, et al.
Publicado: (2014)

Association between Galectin-3 levels within central and peripheral venous blood, and adverse left ventricular remodelling after first acute myocardial infarction
por: Andrejic, Olivera M., et al.
Publicado: (2019)

The Association between Galectin-3 and hs-CRP and the Clinical Outcome after Non-ST-Elevation Myocardial Infarction with Preexisting Atrial Fibrillation
por: Pavlović, Milan, et al.
Publicado: (2017)

Galectin-3 as the Prognostic Factor of Adverse Cardiovascular Events in Long-Term Follow up in Patients after Myocardial Infarction—A Pilot Study
por: Święcki, Przemysław, et al.
Publicado: (2020)

Galectin-3-induced oxidized low-density lipoprotein promotes the phenotypic transformation of vascular smooth muscle cells
por: TIAN, LEI, et al.
Publicado: (2015)

Serum Galectin and Renal Dysfunction in ST-Segment Elevation Myocardial Infarction
por: Karetnikova, Victoria, et al.
Publicado: (2016)

Correlation between Serum ApoC III and Galectin-3 Levels and Maternal and Neonatal Adverse Outcomes in Gestational Diabetes Mellitus Patients
por: Tang, Tingting, et al.
Publicado: (2022)

Trend of Galectin-3 Levels in Patients with Non-ST-Elevation and ST-Elevation Myocardial Infarction
por: Mitić, Branka, et al.
Publicado: (2022)

Macrophages secrete murinoglobulin-1 and galectin-3 to regulate neutrophil degranulation after myocardial infarction
por: Chalise, Upendra, et al.
Publicado: (2022)

The Therapeutic Potential of Blocking Galectin-3 Expression in Acute Myocardial Infarction and Mitigating Inflammation of Infarct Region: A Clinical Outcome-Based Translational Study
por: Mosleh, Wassim, et al.
Publicado: (2018)

Galectin-3 as a Prognostic Biomarker in Patients with First Acute Myocardial Infarction without Heart Failure
por: Vucic, Rada M., et al.
Publicado: (2023)

Galectin-3 is associated with the functional outcome and mortality in stroke patients: A systematic review and meta-analysis
por: Han, Xiaoling, et al.
Publicado: (2023)

Galectin‐3 Is Elevated and Associated With Adverse Outcomes in Patients With Single‐Ventricle Fontan Circulation
por: Opotowsky, Alexander R., et al.
Publicado: (2016)

Plasma Galectin-3 predicts deleterious vascular dysfunction affecting post-myocardial infarction patients: An explanatory study
por: Huttin, Olivier, et al.
Publicado: (2020)

Association between Endothelial Cell-Specific Molecule 1 and Galectin-3 in Patients with ST-Segment Elevation Myocardial Infarction: A Pilot Study
por: Wei, Peng, et al.
Publicado: (2022)

Ticagrelor attenuates myocardial ischaemia–reperfusion injury possibly through downregulating galectin‐3 expression in the infarct area of rats
por: Liu, Xiaogang, et al.
Publicado: (2018)

Correlation between serum laminin levels and prognosis of acute myocardial infarction
por: Xu, Lou-Yuan, et al.
Publicado: (2022)

Symmetric Dimethylarginine is Altered in Patients After Myocardial Infarction and Predicts Adverse Outcomes
por: Gąsecka, Aleksandra, et al.
Publicado: (2021)

Characteristics of Premature Myocardial Infarction Among Women With Prior Adverse Pregnancy Outcomes
por: Countouris, Malamo E., et al.
Publicado: (2023)

Circulating plasma galectin-3 predicts new-onset atrial fibrillation in patients after acute myocardial infarction during hospitalization
por: Wang, Qianhui, et al.
Publicado: (2022)

Correlation between air pollution and hospitalization due to myocardial infarction
por: Davoodabadi, Zeynab, et al.
Publicado: (2019)

Correlation Between Different Parameters of Acute Myocardial Infarction and Obesity
por: Alqahtani, Saad A, et al.
Publicado: (2022)

Variants Tagging LGALS-3 Haplotype Block in Association with First Myocardial Infarction and Plasma Galectin-3 Six Months after the Acute Event
por: Djordjevic, Ana, et al.
Publicado: (2022)

Correlation between leukocyte count and infarct size in ST segment elevation myocardial infarction
por: Ferrari, Júlia Peixoto, et al.
Publicado: (2016)

Prevalence and adverse outcomes of frailty in older patients with acute myocardial infarction after percutaneous coronary interventions: A systematic review and meta‐analysis
por: Yu, Qian, et al.
Publicado: (2022)

ECG Marker of Adverse Electrical Remodeling Post-Myocardial Infarction Predicts Outcomes in MADIT II Study
por: Tereshchenko, Larisa G., et al.
Publicado: (2012)

Glycaemic variability is associated with adverse cardiovascular outcomes in patients hospitalised with an acute myocardial infarction
por: Chai, Thora Y., et al.
Publicado: (2019)

An Elevated Glycemic Gap is Associated with Adverse Outcomes in Diabetic Patients with Acute Myocardial Infarction
por: Liao, Wen-I, et al.
Publicado: (2016)

Hyperuricemia Predicts Adverse Outcomes After Myocardial Infarction With Non-obstructive Coronary Arteries
por: Mohammed, Abdul-Quddus, et al.
Publicado: (2021)

Meta-analysis Comparing Outcomes of Type 2 Myocardial Infarction and Type 1 Myocardial Infarction With a Focus on Dual Antiplatelet Therapy
por: Reid, Christopher, et al.
Publicado: (2020)

cMR in acute myocardial infarction: correlation between myocardial scar and echocardiographic strain
por: Weissman, Gaby, et al.
Publicado: (2012)

Serum irisin correlates to the severity of acute myocardial infarction and predicts the postoperative major adverse cardiovascular events
por: Chai, Qiaoying, et al.
Publicado: (2023)

Statin in the treatment of patients with myocardial infarction: A meta-analysis
por: Han, Xue, et al.
Publicado: (2018)

Serum Galectin-3 level, not Galectin-1, is associated with the clinical feature and outcome in patients with acute ischemic stroke
por: Dong, Han, et al.
Publicado: (2017)

Meta-analysis of the association between Apolipoprotein E polymorphism and risks of myocardial infarction
por: Shao, Aiyu, et al.
Publicado: (2022)

A systematic review and meta-analysis of the association between sarcopenia and myocardial infarction
por: Li, Feika, et al.
Publicado: (2023)

Galectin-3: A Link between Myocardial and Arterial Stiffening in Patients with Acute Decompensated Heart Failure?
por: Lala, Radu Ioan, et al.
Publicado: (2016)

Clinical Relevance of Galectin-1 and Galectin-3 in Rheumatoid Arthritis Patients: Differential Regulation and Correlation With Disease Activity
por: Mendez-Huergo, Santiago P., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4cao07m6kpehh0c3pg3i156ha3